120 related articles for article (PubMed ID: 8005259)
1. Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part II).
Kroegel C; Warner JA; Virchow JC; Matthys H
Eur Respir J; 1994 Apr; 7(4):743-60. PubMed ID: 8005259
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I).
Kroegel C; Virchow JC; Luttmann W; Walker C; Warner JA
Eur Respir J; 1994 Mar; 7(3):519-43. PubMed ID: 8013611
[TBL] [Abstract][Full Text] [Related]
3. Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.
Davis WB; Fells GA; Sun XH; Gadek JE; Venet A; Crystal RG
J Clin Invest; 1984 Jul; 74(1):269-78. PubMed ID: 6330175
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils as a pharmacological target for the treatment of allergic diseases.
Landolina NA; Levi-Schaffer F
Curr Opin Pharmacol; 2014 Aug; 17():71-80. PubMed ID: 25128782
[TBL] [Abstract][Full Text] [Related]
5. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
[TBL] [Abstract][Full Text] [Related]
6. Eosinophils: biological properties and role in health and disease.
Hogan SP; Rosenberg HF; Moqbel R; Phipps S; Foster PS; Lacy P; Kay AB; Rothenberg ME
Clin Exp Allergy; 2008 May; 38(5):709-50. PubMed ID: 18384431
[TBL] [Abstract][Full Text] [Related]
7. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
8. Eosinophils may play regionally disparate roles in influencing IgA(+) plasma cell numbers during large and small intestinal inflammation.
Forman R; Bramhall M; Logunova L; Svensson-Frej M; Cruickshank SM; Else KJ
BMC Immunol; 2016 May; 17(1):12. PubMed ID: 27245920
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil as a therapeutic target in allergic disease.
Mehta H; Busse WW
Compr Ther; 1994; 20(11):651-7. PubMed ID: 7851097
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide-induced chemotaxis of eosinophils in pulmonary diseases.
Dunzendorfer S; Wiedermann CJ
Ann Med; 2000 Oct; 32(7):429-39. PubMed ID: 11087162
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice.
Jacobsen EA; Doyle AD; Colbert DC; Zellner KR; Protheroe CA; LeSuer WE; Lee NA; Lee JJ
Allergy; 2015 Sep; 70(9):1148-59. PubMed ID: 26009788
[TBL] [Abstract][Full Text] [Related]
12. [The study of association of chronic rhinosinusitis inflammation subtype with bronchial inflammation phenotype].
Zhang M; Wang JT; Wu DW; Tan LP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(1):48-52. PubMed ID: 29798210
[No Abstract] [Full Text] [Related]
13. Review article: The eosinophil as a therapeutic target in gastrointestinal disease.
Hogan SP; Rothenberg ME
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1231-40. PubMed ID: 15606385
[TBL] [Abstract][Full Text] [Related]
14. Excretory-secretory products secreted by Paragonimus westermani delay the spontaneous cell death of human eosinophils through autocrine production of GM-CSF.
Shin MH; Seoh JY; Park HY; Kita H
Int Arch Allergy Immunol; 2003 Sep; 132(1):48-57. PubMed ID: 14555858
[TBL] [Abstract][Full Text] [Related]
15. Targeting eosinophil biology in asthma therapy.
Wegmann M
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):667-74. PubMed ID: 21474432
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil tissue recruitment to sites of allergic inflammation in the lung is platelet endothelial cell adhesion molecule independent.
Miller M; Sung KL; Muller WA; Cho JY; Roman M; Castaneda D; Nayar J; Condon T; Kim J; Sriramarao P; Broide DH
J Immunol; 2001 Aug; 167(4):2292-7. PubMed ID: 11490017
[TBL] [Abstract][Full Text] [Related]
17. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis.
Yoshikawa M; Matsumoto K; Iida M; Akasawa A; Moriyama H; Saito H
Int Arch Allergy Immunol; 2002; 128 Suppl 1():3-11. PubMed ID: 12065903
[TBL] [Abstract][Full Text] [Related]
18. Priming and induction of eosinophil trafficking in guinea-pig cutaneous inflammation by tumour necrosis factor alpha.
Macari DM; Teixeira MM; Ansari T; Jeffery PK; Hellewell PG
Br J Pharmacol; 1998 Nov; 125(6):1228-35. PubMed ID: 9863651
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying eosinophil trafficking and their relevance in vivo.
Cara DC; Negrao-Correa D; Teixeira MM
Histol Histopathol; 2000 Jul; 15(3):899-920. PubMed ID: 10963133
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary inflammation workshop.
Payne AN; Selig W
Agents Actions Suppl; 1995; 47():193-7. PubMed ID: 7785499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
